retatrutide type 2 diabetes trial results Eli Lilly just announced striking Phase 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Effects of once-weekly subcutaneous retatrutide

Instead, prioritize lean proteins like chicken and fish, low-sulfur vegetables such as spinach, green beans, and zucchini, and easily digestible carbohydrates like white rice or plain oatmeal during the initial adjustment phase

Notably, around 30% of solid organ transplant recipients experience post-transplant diabetes[1]

Theres a possible increase in the risk of gallbladder disease in people taking semaglutide for more than six months

First-time AOM semaglutide prescribing increased by over 50%, marking the largest quarter-over-quarter increase in first-time AOM semaglutide prescribing since mid-2024, likely driven by the approval of the oral formulation of Wegovy in December 2025

Is compounded semaglutide as good as Wegovy